
miR‑15b, a diagnostic biomarker and therapeutic target, inhibits oesophageal cancer progression by regulating the PI3K/AKT signalling pathway
Author(s) -
Jie Liu,
Haiyan Xu,
Nan Wang,
Meng Sun
Publication year - 2020
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2020.9352
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , cancer research , viability assay , flow cytometry , oncogene , apoptosis , cell growth , cancer , cell cycle , metastasis , biology , cell , microrna , signal transduction , medicine , immunology , microbiology and biotechnology , biochemistry , genetics , gene